135 related articles for article (PubMed ID: 16790816)
1. Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection.
Lean IS; Lacroix-Lamandé S; Laurent F; McDonald V
Infect Immun; 2006 Jul; 74(7):4379-82. PubMed ID: 16790816
[TBL] [Abstract][Full Text] [Related]
2. Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon.
Barakat FM; McDonald V; Foster GR; Tovey MG; Korbel DS
J Infect Dis; 2009 Nov; 200(10):1548-55. PubMed ID: 19821721
[TBL] [Abstract][Full Text] [Related]
3. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection.
Lacroix S; Mancassola R; Naciri M; Laurent F
Infect Immun; 2001 Mar; 69(3):1635-42. PubMed ID: 11179338
[TBL] [Abstract][Full Text] [Related]
4. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.
Rogers KA; Rogers AB; Leav BA; Sanchez A; Vannier E; Uematsu S; Akira S; Golenbock D; Ward HD
Infect Immun; 2006 Jan; 74(1):549-56. PubMed ID: 16369011
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum.
Pollok RC; Farthing MJ; Bajaj-Elliott M; Sanderson IR; McDonald V
Gastroenterology; 2001 Jan; 120(1):99-107. PubMed ID: 11208718
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of interferon-gamma-mediated signalling pathway in intestinal epithelial cells by Cryptosporidium parvum infection.
Choudhry N; Korbel DS; Edwards LA; Bajaj-Elliott M; McDonald V
Cell Microbiol; 2009 Sep; 11(9):1354-64. PubMed ID: 19473199
[TBL] [Abstract][Full Text] [Related]
7. Innate immune responses against Cryptosporidium parvum infection.
McDonald V; Korbel DS; Barakat FM; Choudhry N; Petry F
Parasite Immunol; 2013 Feb; 35(2):55-64. PubMed ID: 23173616
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice.
McDonald V; Deer R; Uni S; Iseki M; Bancroft GJ
Infect Immun; 1992 Aug; 60(8):3325-31. PubMed ID: 1639500
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase, MPO, NE, ERK1/2, p38 MAPK and Ca2+ influx are essential for Cryptosporidium parvum-induced NET formation.
Muñoz-Caro T; Lendner M; Daugschies A; Hermosilla C; Taubert A
Dev Comp Immunol; 2015 Oct; 52(2):245-54. PubMed ID: 26026247
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Cryptosporidium parvum with mouse dendritic cells leads to their activation and parasite transportation to mesenteric lymph nodes.
Perez-Cordon G; Yang G; Zhou B; Nie W; Li S; Shi L; Tzipori S; Feng H
Pathog Dis; 2014 Feb; 70(1):17-27. PubMed ID: 23913680
[TBL] [Abstract][Full Text] [Related]
12. Requirement for TNF-Tnfrsf1 signalling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum.
Ponnuraj EM; Hayward AR
Clin Exp Immunol; 2002 Jun; 128(3):416-20. PubMed ID: 12067295
[TBL] [Abstract][Full Text] [Related]
13. Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.
Robinson P; Okhuysen PC; Chappell CL; Lewis DE; Shahab I; Janecki A; White AC
Infect Immun; 2001 Feb; 69(2):1172-4. PubMed ID: 11160015
[TBL] [Abstract][Full Text] [Related]
14. Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice.
Ehigiator HN; Romagnoli P; Borgelt K; Fernandez M; McNair N; Secor WE; Mead JR
Parasite Immunol; 2005; 27(1-2):17-28. PubMed ID: 15813719
[TBL] [Abstract][Full Text] [Related]
15. Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice.
Ehigiator HN; McNair N; Mead JR
Exp Parasitol; 2007 Feb; 115(2):107-13. PubMed ID: 16920103
[TBL] [Abstract][Full Text] [Related]
16. Host immune response to Cryptosporidium parvum infection.
Petry F; Jakobi V; Tessema TS
Exp Parasitol; 2010 Nov; 126(3):304-9. PubMed ID: 20685209
[TBL] [Abstract][Full Text] [Related]
17. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice.
Smith LM; Bonafonte MT; Mead JR
J Parasitol; 2000 Apr; 86(2):300-7. PubMed ID: 10780549
[TBL] [Abstract][Full Text] [Related]
18. Cryptosporidium parvum infection in gene-targeted B cell-deficient mice.
Chen W; Harp JA; Harmsen AG
J Parasitol; 2003 Apr; 89(2):391-3. PubMed ID: 12760662
[TBL] [Abstract][Full Text] [Related]
19. Roles for NK cells and an NK cell-independent source of intestinal gamma interferon for innate immunity to Cryptosporidium parvum infection.
Barakat FM; McDonald V; Di Santo JP; Korbel DS
Infect Immun; 2009 Nov; 77(11):5044-9. PubMed ID: 19687195
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Th17 associating cytokines in Cryptosporidium parvum-infected mice.
Zhao GH; Fang YQ; Ryan U; Guo YX; Wu F; Du SZ; Chen DK; Lin Q
Parasitol Res; 2016 Feb; 115(2):879-87. PubMed ID: 26593737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
